Company: FVR
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0000950170-25-042774
Chunk: 183

Company: FrontView REIT, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 7
Chunk 183
---
 may not be comparable to similarly titled measures employed by other REITs, and comparisons of our FFO and AFFO with the same or similar measures disclosed by other REITs may not be meaningful. FFO and AFFO should not be considered alternatives to net income as a performance measure or to cash flows from operations, as reported on our statement of cash flows, or as a liquidity measure, and should be considered in addition to, and not in lieu of, GAAP financial measures. 

Neither the SEC nor any other regulatory body has passed judgment on the acceptability of the adjustments to FFO that we use to calculate AFFO. In the future, the SEC, Nareit or another regulatory body may decide to standardize the allowable adjustments across the REIT industry and in response to such standardization we may have to adjust our calculation and characterization of AFFO accordingly. 

57

The following is a reconciliation of historical and pro forma net income (which is the most comparable GAAP measure) to FFO and AFFO:

Reconciliation of Historical and pro forma net income to FFO and AFFO

    Successor

    Successor

    Predecessor

    Predecessor

    Pro Forma

    Historical

    Historical

    Historical

    (in thousands)
     
    Year Ended December 31, 2024

    Period from October 3, 2024 through December 31, 2024

    Period from January 1, 2024 through October 2, 2024

    Year Ended December 31, 2023

    Net loss
     
    $
    (26,613
    )
     
    $
    (4,822
    )
     
    $
    (26,387
    )
     
    $
    (1,524
    )

    Depreciation on real property and amortization of real estate intangibles

    33,357

    7,468

    21,581

    24,730

    Share of 50/50 Joint Venture's depreciation on real property and amortization of real estate intangibles

    —

    —

    —

    1,798

    Gain on sale of real estate

    —

    —

    (337
    )

    (725
    )

    Share of 50/50 Joint Venture's gain on sale of real estate

    —

    —

    —

    (260
    )

    Impairment loss on